Please login to the form below

Not currently logged in
Email:
Password:

Lyell Immunopharma

This page shows the latest Lyell Immunopharma news and features for those working in and with pharma, biotech and healthcare.

GSK pays $50m upfront to tap Immatics’ cell therapy platform

GSK pays $50m upfront to tap Immatics’ cell therapy platform

Last year, it signed a five-year collaboration with Lyell Immunopharma that is also aimed at the development of cell therapies for solid tumours. ... Lyell’s technology will be used to improve GSK’s cell therapy candidates, including GSK3377794,

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...

Latest intelligence

Ask the writers: Transitioning from academia to medical writing
Porterhouse Medical's talented writers talk about their transition from academia and give advice to those people considering a career in medical writing...
Strategic launch planning: familiar framework, new mindset
By James Aird...
Guide
How to embrace behavioural science principles in healthcare MR...